Gavin McLaughlin, Michael H. Baumann, Pierce V. Kavanagh, Noreen Morris, John D. Power: Synthesis, analytical characterization, and monoamine transporter activity of the new psychoactive substance 4-methylphenmetrazine (4-MPM), with differentiation from its ortho - and meta - positional isomers. In: Drug Testing and Analysis. Band10, Nr.9, September 2018, S.1404–1416, doi:10.1002/dta.2396, PMID 29673128, PMC 7316143 (freier Volltext).
Hampson, J, J.A. Loraine, J.A. Strong: Phenmetrazine and Dexamphetamine in the Management of Obesity. In: The Lancet. 275. Jahrgang, Nr.7137, 1960, S.1265–7, doi:10.1016/S0140-6736(60)92250-9, PMID 14399386.
Engelhardt, A: Studies of the Mechanism of the Anti-Appetite Action of Phenmetrazine. In: Biochem. Pharmacol. 8. Jahrgang, Nr.1, 1961, S.100, doi:10.1016/0006-2952(61)90520-2.
Choi H, Baeck S, Jang M, Lee S, Choi H, Chung H: Simultaneous analysis of psychotropic phenylalkylamines in oral fluid by GC-MS with automated SPE and its application to legal cases. In: Forensic Science International. 215. Jahrgang, Nr.1–3, 10. Februar 2012, S.81–87, doi:10.1016/j.forsciint.2011.02.011, PMID 21377815.
Patent US2835669A: Process for the production of substituted morpholines. Angemeldet am 29. Juni 1953, veröffentlicht am 20. Mai 1958, Erfinder: Otto Thoma. Priorität (nationale Erstanmeldung): 1. Juli 1952 (DE).
Patent US20130203752: Phenylmorpholines and analogues thereof. Veröffentlicht am 20. Mai 2011, Erfinder: Bruce E. Blough, Richard Rothman, Antonio Landavazo, Kevin M. Page, Ann Marie Decker.
Antonio Martel: Preludin (Phenmetrazine) in the Treatment of Obesity. In: Can. Med. Assoc. J. 76. Jahrgang, Nr.2, 1957, S.117–20, PMID 13383418, PMC 1823494 (freier Volltext).
Gavin McLaughlin, Michael H. Baumann, Pierce V. Kavanagh, Noreen Morris, John D. Power: Synthesis, analytical characterization, and monoamine transporter activity of the new psychoactive substance 4-methylphenmetrazine (4-MPM), with differentiation from its ortho - and meta - positional isomers. In: Drug Testing and Analysis. Band10, Nr.9, September 2018, S.1404–1416, doi:10.1002/dta.2396, PMID 29673128, PMC 7316143 (freier Volltext).
PHENMETRAZINE hydrochloride. In: Journal of the American Medical Association. Band 163, Nummer 5, Februar 1957, S. 357, PMID 13385162.
Hampson, J, J.A. Loraine, J.A. Strong: Phenmetrazine and Dexamphetamine in the Management of Obesity. In: The Lancet. 275. Jahrgang, Nr.7137, 1960, S.1265–7, doi:10.1016/S0140-6736(60)92250-9, PMID 14399386.
Choi H, Baeck S, Jang M, Lee S, Choi H, Chung H: Simultaneous analysis of psychotropic phenylalkylamines in oral fluid by GC-MS with automated SPE and its application to legal cases. In: Forensic Science International. 215. Jahrgang, Nr.1–3, 10. Februar 2012, S.81–87, doi:10.1016/j.forsciint.2011.02.011, PMID 21377815.
